Patent Yard Sign in
Canadian application, no grantCanada

Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds

CA 2434727 A1 · Owner: Adams, Mark E. · Inventors: Edwards, James P.; Deckhut, Charlotte L. F.; Higuchi, Robert I.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel non-steroidal tricyclic quinolinone and tricyclic quinoline compounds and compositions that are agonists, partial agonists and/or antagonists for androgen receptors (AR), their preparation and their uses are described.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 23, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 23, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 23, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 23, 2002
GrantedNo grant recorded
Term endedFebruary 23, 2022
Patent numberCA 2434727 A1
Classification (IPC)C07D498/04 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedFeb 23, 2002Term endedFeb 23, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.